Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SNX
|
Kevin M Murai
Director |
SELL
Open market or private sale
|
Direct | 3,300 Reduced 2.42% |
$280,500
$85.0 p/Share
|
May 20
2016 |
|
SNX
|
Kevin M Murai
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 3,300 Added 2.36% |
$102,168
$30.96 p/Share
|
May 20
2016 |
|
PSX
|
Berkshire Hathaway Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 257,248 Added 0.34% |
$20,044,764
$77.92 p/Share
|
May 20
2016 |
|
PEN
|
Robert D. Evans
EVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Indirect | 3,000 Reduced 1.03% |
$150,060
$50.02 p/Share
|
May 20
2016 |
|
TMUS
|
Thomas Christopher Keys
Pres. MetroPCS |
SELL
Open market or private sale
|
Direct | 28,875 Reduced 7.23% |
$1,209,285
$41.88 p/Share
|
May 20
2016 |
|
TMUS
|
Thomas Christopher Keys
Pres. MetroPCS |
BUY
Exercise of conversion of derivative security
|
Direct | 28,875 Added 6.74% |
$1,094,651
$37.91 p/Share
|
May 20
2016 |
|
SNPS
|
Chi Foon Chan
Co-CEO |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 1.01% |
$99,300
$49.65 p/Share
|
May 20
2016 |
|
MRK
|
Clark Golestani
EVP & Chief Info Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 38,647 Added 40.95% |
$1,738,342
$44.98 p/Share
|
May 20
2016 |
|
MRK
|
Clark Golestani
EVP & Chief Info Officer |
SELL
Open market or private sale
|
Direct | 38,647 Reduced 69.35% |
$2,117,856
$54.8 p/Share
|
May 20
2016 |
|
ISGN
|
Philip S Sassower
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 228,556 Added 41.2% |
$397,687
$1.74 p/Share
|
May 19
2016 |
|
ISGN
|
Philip S Sassower
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 93,717 Added 48.99% |
$695,380
$7.42 p/Share
|
May 19
2016 |
|
OPGN
|
Merck & Co., Inc.
> 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect | 1,200,000 Added 30.94% |
-
|
May 19
2016 |
|
KO
|
Brian John Smith |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 70.48% |
$2,216,000
$44.32 p/Share
|
May 19
2016 |
|
KO
|
Brian John Smith |
BUY
Exercise of conversion of derivative security
|
Direct | 50,000 Added 41.34% |
$1,388,500
$27.77 p/Share
|
May 19
2016 |
|
NVDA
|
Michael Byron
Principal Accounting Officer |
SELL
Open market or private sale
|
Direct | 19,347 Reduced 11.1% |
$839,273
$43.38 p/Share
|
May 19
2016 |
|
NVDA
|
Robert K Burgess
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,213 Added 9.07% |
-
|
May 19
2016 |
|
NVDA
|
Persis Drell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,213 Added 17.39% |
-
|
May 19
2016 |
|
NVDA
|
Dawn E Hudson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,213 Added 17.25% |
-
|
May 19
2016 |
|
NVDA
|
Harvey C Jones
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,213 Added 17.79% |
-
|
May 19
2016 |
|
NVDA
|
Michael G Mccaffery
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,213 Added 17.39% |
-
|
May 19
2016 |
|
NVDA
|
William J Miller
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,213 Added 13.18% |
-
|
May 19
2016 |
|
NVDA
|
Mark L Perry
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,213 Added 9.07% |
-
|
May 19
2016 |
|
NVDA
|
A Brooke Seawell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,213 Added 35.37% |
-
|
May 19
2016 |
|
NVDA
|
Mark A Stevens
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,213 Added 16.58% |
-
|
May 19
2016 |
|
NVDA
|
James C Gaither
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,213 Added 11.9% |
-
|
May 19
2016 |
|
NVDA
|
Tench Coxe
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,213 Added 5.61% |
-
|
May 19
2016 |
|
PSX
|
Berkshire Hathaway Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 189,189 Added 0.12% |
$14,682,958
$77.61 p/Share
|
May 19
2016 |
|
PEN
|
Don W. Kassing
Director |
SELL
Open market or private sale
|
Indirect | 3,000 Reduced 18.75% |
$145,890
$48.63 p/Share
|
May 19
2016 |
|
PEN
|
James Robert Pray
President, International |
BUY
Grant, award, or other acquisition
|
Direct | 1,447 Added 0.23% |
$36,898
$25.5 p/Share
|
May 19
2016 |
|
PEN
|
Lynn Rothman
EVP and Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,666 Added 0.75% |
$42,483
$25.5 p/Share
|
May 19
2016 |
|
PEN
|
Robert D. Evans
EVP, Gen. Counsel & Secretary |
BUY
Open market or private purchase
|
Direct | 1,538 Added 37.73% |
$39,219
$25.5 p/Share
|
May 19
2016 |
|
TSLA
|
Elon Musk
CEO |
SELL
Bona fide gift
|
Indirect | 1,200,000 Reduced 3.42% |
-
|
May 19
2016 |
|
TSLA
|
Elon Musk
CEO |
BUY
Exercise of conversion of derivative security
|
Indirect | 5,503,972 Added 7.54% |
$36,491,335
$6.63 p/Share
|
May 19
2016 |
|
ARE
|
James H Richardson
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 3.45% |
$232,450
$92.98 p/Share
|
May 19
2016 |
|
CVS
|
Richard J Swift
Director |
BUY
Grant, award, or other acquisition
|
Direct | 612 Added 10.86% |
$61,781
$100.95 p/Share
|
May 19
2016 |
|
CVS
|
Richard M Bracken
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,095 Added 21.8% |
$110,540
$100.95 p/Share
|
May 19
2016 |
|
CVS
|
Nancy Ann Deparle
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,040 Added 16.29% |
$104,988
$100.95 p/Share
|
May 19
2016 |
|
CVS
|
David W Dorman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,823 Added 3.91% |
$284,982
$100.95 p/Share
|
May 19
2016 |
|
CVS
|
Anne A. Finucane
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,040 Added 50.0% |
$104,988
$100.95 p/Share
|
May 19
2016 |
|
CVS
|
Jean Pierre Millon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,040 Added 50.0% |
$104,988
$100.95 p/Share
|
May 19
2016 |
|
CVS
|
Tony L White
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,040 Added 4.84% |
$104,988
$100.95 p/Share
|
May 19
2016 |
|
NEE
|
James L Robo
Director |
SELL
Open market or private sale
|
Direct | 43,773 Reduced 11.28% |
$5,138,950
$117.4 p/Share
|
May 19
2016 |
|
NEE
|
James L Robo
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 43,773 Added 10.14% |
$2,584,796
$59.05 p/Share
|
May 19
2016 |
|
MRK
|
Clark Golestani
EVP & Chief Info Officer |
SELL
Open market or private sale
|
Direct | 1,230 Reduced 6.72% |
$67,096
$54.55 p/Share
|
May 19
2016 |
|
HD
|
William G. Lennie
Executive Vice President |
SELL
Open market or private sale
|
Direct | 22,996 Reduced 34.42% |
$3,021,444
$131.39 p/Share
|
May 19
2016 |
|
HD
|
William G. Lennie
Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 23,746 Added 26.22% |
$973,823
$41.01 p/Share
|
May 19
2016 |
|
HD
|
William G. Lennie
Executive Vice President |
SELL
Bona fide gift
|
Direct | 750 Reduced 1.71% |
-
|
May 19
2016 |
|
HD
|
Craig A Menear
Chair |
SELL
Open market or private sale
|
Direct | 46,227 Reduced 24.48% |
$6,072,841
$131.37 p/Share
|
May 19
2016 |
|
HD
|
Craig A Menear
Chair |
BUY
Exercise of conversion of derivative security
|
Direct | 46,227 Added 19.66% |
$1,795,919
$38.85 p/Share
|
May 19
2016 |
|
HZNP
|
Barry Moze
EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,000 Reduced 11.29% |
$73,050
$14.61 p/Share
|
May 19
2016 |